Gyre Therapeutics, Inc. (“Gyre”, “Gyre Therapeutics” or the “Company”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company with operations in the United States and China, today ...

The liver is often called a "silent organ," as it can sustain significant damage without obvious symptoms. But when injury is ...

Liver fibrosis is a feature of many hepatic diseases, including metabolic dysfunction-associated steatohepatitis (MASH). Various candidate drugs directly targeting mechanisms of fibrosis have shown ...

Please provide your email address to receive an email when new articles are posted on . Noninvasive tests for liver fibrosis screening performed worse among Black adults vs. other racial-ethnic groups ...

Researchers at UCLA Health uncovered new information about the role inflammation plays in mitigating liver fibrosis, which is associated with metabolic-associated fatty liver disease (MAFLD), one of ...

It turns out your morning cup of joe could be supporting overall liver health.

Please provide your email address to receive an email when new articles are posted on . After screening, excessive drinking decreased from 46% to 32% at 6 months among those at risk for ALD. After 6 ...

An AI-powered blood test that analyzes DNA fragments could detect silent liver disease long before symptoms begin.

BOSTON — In the staging of liver fibrosis in the post-liver transplant setting, readings from noninvasive tests commonly have major discrepancies when compared with liver biopsy results, particularly ...

A review included more than 600,000 people to highlight that what we eat—not just what we drink—impacts liver health.

Eli Lilly metabolic disorder medication tirzepatide, already approved in type 2 diabetes and weight management, now has early clinical data indicating it can also help patients with a fatty liver ...